AndreaBozzo/ceres-open-data-index huggingface dataset:
NorWeST Stream Temperatures 2040s (Feature Layer)

This layer represents modeled stream temperatures derived from the 
NorWeST point feature class (NorWest_TemperaturePoints). NorWeST summer 
stream temperature scenarios were developed for all rivers and streams 
in the western U.S. from the &gt; 20,000 stream sites in the NorWeST 
database where mean August stream temperatures were recorded. The 
resulting dataset includes stream lines (NorWeST_PredictedStreams) and 
associated mid-points NorWest_TemperaturePoints) representing 1 
kilometer intervals along the stream network. Stream lines were derived 
from the 1:100,000 scale NHDPlus dataset (USEPA and USGS 2010; McKay et 
al. 2012). Shapefile extents correspond to NorWeST processing units, 
which generally relate to 6 digit (3rd code) hydrologic unit codes 
(HUCs) or in some instances closely correspond to state borders. The 
line and point shapefiles contain identical modeled stream temperature 
results. The two feature classes are meant to complement one another for
 use in different applications. In addition, spatial and temporal 
covariates used to generate the modeled temperatures are included in the
 attribute tables at 
https://www.fs.usda.gov/rm/boise/AWAE/projects/NorWeST/ModeledStreamTemperatureScenarioMaps.shtml.
 The NorWeST NHDPlusV1 processing units include: Salmon, Clearwater, 
Spokoot, Missouri Headwaters, Snake-Bear, MidSnake, MidColumbia, Oregon 
Coast, South-Central Oregon, Upper Columbia-Yakima, Washington Coast, 
Upper Yellowstone-Bighorn, Upper Missouri-Marias, and Upper Green-North 
Platte. The NorWeST NHDPlusV2 processing units include: Lahontan Basin, 
Northern California-Coastal Klamath, Utah, Coastal California, Central 
California, Colorado, New Mexico, Arizona, and Black Hills.
HHS Metadata Standard

HHS Metadata Standard: Version 1.0, published in July 2025, serves as the authoritative framework for defining HHS metadata—data about data—fields and attributes. Aligned with the Evidence Act and HealthData.gov, this standard establishes clear guidelines for metadata collection and public sharing across all data assets created, collected, managed, or maintained by HHS. It outlines required metadata fields for HHS datasets, ensuring consistency, interoperability, and discoverability in HHS data governance.
Compound 527846: 2,4-Dichlorobenzyl hexyl ether

Chemical compound data from PubChem database. IUPAC Name: 2,4-dichloro-1-(hexoxymethyl)benzene. Molecular Formula: C13H18Cl2O. Molecular Weight: 261.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530169: 4-Hydroxy-N'-((4Z,5E)-5-(hydroxyimino)-6,7-dihydro-2,1,3-benzoxadiazol-4(5H)-ylidene)benzohydrazide

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 5-oxo-2,5-bis(trimethylsilylamino)pentanoate. Molecular Formula: C14H34N2O3Si3. Molecular Weight: 362.69. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Electroacupuncture versus Diclofenac in symptomatic treatment of Osteoarthritis of the knee: a randomized controlled trial

Background
          The purpose of this study was to compare the efficacy of electroacupuncture (EA), diclofenac and their combination in symptomatic treatment of osteoarthritis (OA) of the knee.
        
        
          Methods
          This study was a randomized, single-blind, placebo controlled trial. The 193 out-patients with OA of the knee were randomized into four groups: placebo, diclofenac, EA and combined (diclofenac plus EA). Paracetamol tablets were prescribed as a rescue analgesic during the study. The patients were evaluated after a run-in period of one week (week 0) and again at the end of the study (week 4). The clinical assessments included the amount of paracetamol taken/week, visual analog scale (VAS), Western Ontario and McMaster Universities (WOMAC) OA Index, Lequesne's functional index, 50 feet-walk time, and the orthopedist's and patient's opinion of change.
        
        
          Results
          One hundred and eighty six patients completed the study. The improvement of symptoms (reduction in mean changes) in most outcome parameters was greatest in the EA group. The proportions of responders and patients with an overall opinion of "much better" were also greatest in the EA group. The improvement in VAS was significantly different between the EA and placebo group as well as the EA and diclofenac group. The improvement in Lequesne's functional index also differed significantly between the EA and placebo group. In addition, there was a significant improvement in WOMAC pain index between the combined and placebo group.
        
        
          Conclusion
          EA is significantly more effective than placebo and diclofenac in the symptomatic treatment of OA of the knee in some circumstances. However, the combination of EA and diclofenac treatment was no more effective than EA treatment alone.
Patent AT-E400726-T1: [Translated] SYSTEM AND METHOD FOR REDUCING ERUPTION CROSS IMPACT DURING ERUPTION CROSS DRILLING OPERATIONS

A system and method for lessening impact on Christmas trees during downhole operations involving Christmas trees, by way of example and not limitation such as cementing processes. The system comprises an outer housing defining a chamber, a lubricator assembly disposed in the outer housing, and an inner sleeve slidably disposable within the chamber. The method uses the system of the present invention by inserting the inner sleeve into the lubricator assembly; lowering the inner sleeve into the Christmas tree to a predetermined position extending into a tubing hanger associated with the tree; introducing fluids through a fluid line coupled to the lubricator assembly, the fluids passing through a conduit within the inner sleeve into the wellbore; and retrieving the lubricator assembly upon completion of fluid introduction into the wellbore. In alternative embodiments, the inner sleeve may be retracted and withdrawn with the lubricator assembly upon completion of fluid introduction into the wellbore.
2009-2010 State-specific Tables

This page presents the tables of State-specific tables of State estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Results are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 526304: 1,9-Dibromo-2,8-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,9-dibromo-2,8-dichlorodibenzo-p-dioxin. Molecular Formula: C12H4Br2Cl2O2. Molecular Weight: 410.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529048: Hydroxyacetic acid, pentylboronate

Chemical compound data from PubChem database. IUPAC Name: 2-pentyl-1,3,2-dioxaborolan-4-one. Molecular Formula: C7H13BO3. Molecular Weight: 155.99. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
PII - Evaluation Team (PII-ET)

The Evaluation Team (ET), overseen by the Office of Planning, Research & Evaluation, is charged with designing and carrying out a cross-site evaluation and rigorous, grantee-specific evaluations. PII-ET examines the implementation and effectiveness of the evidence-supported interventions developed and adapted under PII.

Learn more about PII-ET.

Materials

Metadata-only record linking to the original dataset. Open original dataset below.
Cell-cell interactions in synovitis: Interactions between T lymphocytes and synovial cells

Mechanisms whereby T lymphocytes contribute to synovial inflammation in rheumatoid arthritis are poorly understood. Here we review data that indicate an important role for cell contact between synovial T cells, adjacent macrophages and fibroblast-like synoviocytes (FLS). Thus, T cells activated by cytokines, endothelial transmigration, extracellular matrix or by auto-antigens can promote cytokine, particularly TNFα, metalloproteinase production by macrophages and FLS through cell-membrane interactions, mediated at least through β-integrins and membrane cytokines. Since soluble factors thus induced may in turn contribute directly to T cell activation, positive feedback loops are likely to be created. These novel pathways represent exciting potential therapeutic targets.
Compound 528009: 3-Butenyl 3,5-dinitrobenzoate

Chemical compound data from PubChem database. IUPAC Name: but-3-enyl 3,5-dinitrobenzoate. Molecular Formula: C11H10N2O6. Molecular Weight: 266.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Reduced natriuretic response to acute sodium loading in COMT Gene deleted mice

Background
          The intrarenal natriuretic hormone dopamine (DA) is metabolised by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). Inhibition of COMT, as opposed to MAO, results in a potent natriuretic response in the rat. The present study in anaesthetized homozygous and heterozygous COMT gene deleted mice attempted to further elucidate the importance of COMT in renal DA and sodium handling. After acute intravenous isotonic sodium loading, renal function was followed.
        
        
          Results
          COMT activity in heterozygous mice was about half of that in wild type mice and was zero in the homozygous mice. MAO activity did not differ between the genotypes. Urinary sodium excretion increased 10-fold after sodium loading in wild type mice. In heterozygous and homozygous mice, the natriuretic effects of sodium loading were only 29 % and 39 %, respectively, of that in wild type mice. Arterial pressure and glomerular filtration rate did not differ between genotypes. Baseline norepinephrine and DA excretions in urine were elevated in the homozygous, but not in heterozygous, COMT gene deleted mice. Urinary DA excretion increased after isotonic sodium loading in the wild type mice but not in the COMT gene deleted mice.
        
        
          Conclusions
          Mice with reduced or absent COMT activity have altered metabolism of catecholamines and are unable to increase renal DA activity and produce normal natriuresis in response to acute sodium loading. The results support the hypothesis that COMT has an important role in the DA-mediated regulation of renal sodium excretion.
Compound 529001: Tricosane, 1,2-bis(methylthio)

Chemical compound data from PubChem database. IUPAC Name: 1,2-bis(methylsulfanyl)tricosane. Molecular Formula: C25H52S2. Molecular Weight: 416.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399634-T1: [Translated] METHOD FOR PRODUCING AND PRINTING ASTIGMATIC CONTACT LENSES

Chemical patent from PubChem database. Patent Number: AT-E399634-T1. Title: Novel Chemical Entity. Filing Date: 2012-05-13. Inventors: Garcia, Maria, Miller, Thomas. Abstract: The invention relates to a novel chemical entity with unique structural features and biological properties, suitable for development as a therapeutic ... IPC Classifications: C12N, C12P, A61K. This patent covers 42 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Tissue factor as a proinflammatory agent

Tissue factor (TF) is a transmembrane glycoprotein and the main triggering element of blood coagulation. TF expression on monocytes and endothelial cells is induced by exposure to endotoxin, tumor necrosis factor, and IL-1 and is considered to appear in consequence of inflammation. In order to assess the proinflammatory capacity of TF itself, the recombinant extracellular domain of TF was injected intra-articularly into healthy mice. To characterize the role of immune cells in the TF-induced arthritis, mice deprived of lymphocytes, neutrophils and monocytes were used. Histomorphological analysis of the joints with respect to inflammatory cell infiltration, pannus formation and erosion formation revealed development of arthritis in 80% of animals injected with TF. In most of the cases synovial proliferation was accompanied by pannus formation and cartilage destruction. Inflammatory cell infiltrate consisted of CD4-Mac1+ macrophages. Depletion of monocytes was, however, not enough to abolish inflammation. Indeed, combined deficiency of monocytes and lymphocytes was required to prevent inflammation following the injection of TF. We observed that TF induced chemokine production (MIP-1α and RANTES), but did not induce a proliferative response nor cytokine release by mouse spleen cells. TF has strong inflammatogenic properties mediated predominantly by monocytes and their release of chemokines. Our study shows that TF can simultaneously trigger the immune and coagulation systems.
Patent AT-E399646-T1: [Translated] PRINT CARTRIDGE WITH TWO-DIMENSIONAL CODE IDENTIFICATION

A print roll unit includes an elongate ink reservoir core defining a plurality of ink chambers, each extend along the core. The chambers are isolated so as to be each capable of storing a respective type of ink. A roll of print media includes a tubular former in which the core can be received and a length of print media which is wound upon the former. A housing includes a pair of molded covers which can be releasably fastened together to house the roll of print media.
Managed Care Institutional Provider Network Data: December 31, 2015

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects institutional provider data. Provider Network Data System information is self reported. For more information, go to http://www.health.ny.gov/health_care/managed_care/.
Workforce Part 4 — Creating Change at the Local Level

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530555: 4-Ethylbenzoic acid, tetradecyl ester

Chemical compound data from PubChem database. IUPAC Name: tetradecyl 4-ethylbenzoate. Molecular Formula: C23H38O2. Molecular Weight: 346.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530266: Cyclopentane, 1-ethyl-1,3-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 1-ethyl-1,3-dimethylcyclopentane. Molecular Formula: C9H18. Molecular Weight: 126.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399621-T1: [Translated] HANDLE ARRANGEMENT FOR HAND TOOLS

The assembly has a housing defining a handle (4) and accommodating a motor for actuating the output member of a power tool e.g. drill bit or jigsaw blade. A flexible sheet (8) is mounted to the surface of the handle and has a series of protrusions (10) to be engaged by the hand of a user. The protrusions retain a gaseous vibration damping material e.g. air between flexible sheet and surface of handle.
Compound 529133: 1-Butanol, 4-amino, N-isopropylidene

Chemical compound data from PubChem database. IUPAC Name: 4-(propan-2-ylideneamino)butan-1-ol. Molecular Formula: C7H15NO. Molecular Weight: 129.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Drug Abuse Warning Network (DAWN-2007)

<p>The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.<br />
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.<br />
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year.  Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.This study has 1 Data Set.</p>
Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis

Aseptic loosening of total joint arthroplastics due to periprosthetic osteolysis is a frequent cause of implant failure. The absence of clinical interventions to arrest or prevent this complication limits the use of total joint replacement especially in younger patients. Here we review recent studies implicating tumor necrosis factor (TNF)-α in periprosthetic osteolysis and the rationale for clinical studies of anti-TNF therapy and other interventions for periprosthetic loosening.
Patent AT-E400288-T1: [Translated] PEPTIDES HIGH IN CYSTEINE

The invention relates to cysteine containing peptides of the structure XXCCXXXXXXXCXXXCXXXXXXQXXCXXXCXCXXXXXXXCXXXXXX, of the structure XXCCXXXXXXXCXXXCXXXXXXXXXCXXXCXCXXXXTXXCXXXXXX and of the structure XXCCXXXXXXXCXXXCXXXXXXXXXXCXXXCXCXXXXXXXXCXXXXXX, wherein X, independently of one another, represents any naturally occurring amino acid, as well as to nucleic acid sequences encoding said peptides, to vectors comprising said sequences, as well as to pharmaceutical compositions containing said peptides and their use as pharmaceutics, particularly for the treatment of cancers.
Patent AT-E400167-T1: [Translated] AGRICULTURAL MACHINE FOR INCORPORATING LIQUID SUBSTANCES INTO THE SOIL

This invention relates to a machine designed to perform a complete spray treatment on agricultural land by incorporating in the soil liquid substances such as plant protection products, weedkillers, fertilisers and soil conditioners. The machine according to the invention is suitable in particular for treatments, such as fumigation of agricultural land, which involve incorporating into the soil liquid substances that subsequently evaporate and perform their function in the gaseous state.  Said machine, which is of the type comprising:  first means (3) designed to spray said soil with said liquid substances;  second means (8) designed to break up said soil and mix it with said sprayed liquid substances;  third means (5) designed to compact said sprayed soil, creating a compact crust which prevents the exit of the fumes generated by the evaporation of said liquid substances sprayed by said first means (3);  nis characterised in that said first means (3), designed to spray said soil with said liquid substances, are positioned in the immediate vicinity of said second means (8), designed to crush said soil and mix it with said sprayed liquid substances, in such a way that said liquid substances are mixed with said soil simultaneously with spraying, and that said second means (8) include a stone-burying machine.
Patent AT-E401681-T1: [Translated] ELECTRICAL CONNECTOR

The device has two parts (12,14) that can be plugged together and that can be coupled by a sliding element (16) fed into one connector part, especially transversely to the plugging direction, and a securing element (24) movable between a starting position and an end position in which it fixes the sliding part in its end position. The securing element is locked in its starting position and is only released for movement to its end position with the connector parts coupled.